Murayama Kenichiro, Okada Michiaki, Tanaka Kenichi, Inadomi Chika, Yoshioka Wataru, Kubotsu Yoshihito, Yada Tomomi, Isoda Hiroshi, Kuwashiro Takuya, Oeda Satoshi, Akiyama Takumi, Oza Noriko, Hyogo Hideyuki, Ono Masafumi, Kawaguchi Takumi, Torimura Takuji, Anzai Keizo, Eguchi Yuichiro, Takahashi Hirokazu
Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Department of Hepatobiliary and Pancreatology, Saga Medical Center Koseikan, Saga 840-8571, Japan.
Diagnostics (Basel). 2021 Jan 16;11(1):132. doi: 10.3390/diagnostics11010132.
Access to imaging is limited for diagnosing nonalcoholic fatty liver disease (NAFLD) in general populations. This study evaluated the diagnostic performance of noninvasive and nonimaging indexes to predict NAFLD in the general Japanese population. Health checkup examinees without hepatitis virus infection or habitual alcohol drinking were included. Fatty liver was diagnosed by ultrasonography. The hepatic steatosis index (HSI), Zhejiang University (ZJU) index, and fatty liver index (FLI) were determined, and risk of advanced liver fibrosis was evaluated by the fibrosis-4 index. NAFLD was diagnosed in 1935 (28.0%) of the 6927 subjects. The area under the receiver operating characteristic (AUROC) curve of the HSI, ZJU index, and FLI was 0.874, 0.886, and 0.884, respectively. The AUROC of the ZJU index ( < 0.001) and FLI ( = 0.002) was significantly greater than that for the HSI. In subjects with a high risk of advanced fibrosis, the sensitivity of the HSI, ZJU index, and FLI were 88.8%, 94.4%, and 83.3% with a low cut-off value and the specificity was 98.5%, 100%, and 100% with a high cut-off value. In conclusion, all indexes were useful to diagnose NAFLD in the general Japanese population and in subjects with potentially advanced liver fibrosis.
在普通人群中,用于诊断非酒精性脂肪性肝病(NAFLD)的影像学检查受限。本研究评估了非侵入性和非影像学指标对日本普通人群中NAFLD的诊断效能。纳入无肝炎病毒感染或无习惯性饮酒的健康体检者。通过超声检查诊断脂肪肝。计算肝脂肪变性指数(HSI)、浙江大学(ZJU)指数和脂肪肝指数(FLI),并通过Fibrosis-4指数评估进展期肝纤维化风险。6927名受试者中,1935名(28.0%)被诊断为NAFLD。HSI、ZJU指数和FLI的受试者工作特征曲线下面积(AUROC)分别为0.874、0.886和0.884。ZJU指数(<0.001)和FLI(=0.002)的AUROC显著高于HSI。在进展期纤维化高风险受试者中,HSI、ZJU指数和FLI在低临界值时的敏感度分别为88.8%、94.4%和83.3%,在高临界值时的特异度分别为98.5%、100%和100%。总之,所有指标对诊断日本普通人群及潜在进展期肝纤维化受试者的NAFLD均有用。